Press release | Official website vaccine against COVID-19 Sputnik V.

Main
Newsroom
Press Releases

Press Releases

The Gamaleya Center study in animals shows the intranasally delivered Sputnik V vaccine induces robust and durable immune response to coronavirus

Press release, 31.08.2022

The Gamaleya Center has developed a Delta- and Omicron-adapted Sputnik V vaccine

Press release, 23.08.2022

Sputnik V demonstrates 97% efficacy against hospitalisation caused by Omicron variant following revaccination with Sputnik Light or Sputnik V according to a study published in the Vaccines peer-reviewed leading medical journal

Press release, 15.06.2022

Sputnik V demonstrates strong protection against Omicron variant according to a unique independent comparative study conducted by the Spallanzani Institute in Italy with results published in the Vaccines peer-reviewed leading medical journal

Press release, 25.05.2022

Sputnik V becomes the world’s first COVID vaccine with proven efficacy for people living with HIV as demonstrated by a joint study between the Gamaleya Center and Moscow City Center for AIDS Prevention and Control published in The Lancet

Press release, 28.03.2022

RDIF statement

Press release, 28.02.2022

Kazakhstan becomes the first country outside Russia to authorize Sputnik M vaccine for adolescents

Press release, 22.02.2022

Sputnik Light can become a major booster for those vaccinated with inactivated Chinese COVID vaccines globally after China has officially recommended mix & match approach with adenoviral vector-based vaccines as boosters

Press release, 21.02.2022

Clinical trials in Russia and Azerbaijan demonstrated safety of AstraZeneca and Sputnik Light vaccines combination

Press release, 14.02.2022

The one-component Sputnik Light vaccine has been authorized in India; over 2.5 billion people live in countries that approved Sputnik Light as a standalone vaccine and a universal booster

Press release, 06.02.2022

1 2 3 4 5